600645.SS实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 15:00):

Vcanbio Cell & Gene Engineering Corp., Ltd, together with its subsidiaries, primarily engages in the preparation and storage of cell tests in the People's Republic of China...

Stats
今日成交量	4.61M
平均成交量	5.94M
市值	7.68B
EPS	CNY0 ( 2024-04-25 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	58.75
ATR14	CNY0.0260 (0.16%)

音量相关性

長: 0.01 (neutral)

短: 0.81 (strong)

Signal:(56.413) Same movement expected

Vcanbio Cell & Gene 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Vcanbio Cell & Gene 相关性 - 货币/商品

0.38
( neutral )

0.43
( neutral )

0.00
( neutral )

-0.25
( neutral )

0.13
( neutral )

Vcanbio Cell & Gene 财务报表

Annual	2022
营收:	CNY1.55B
毛利润:	CNY1.05B (67.65 %)
EPS:	CNY0.240

FY	2022
营收:	CNY1.55B
毛利润:	CNY1.05B (67.65 %)
EPS:	CNY0.240

FY	2021
营收:	CNY1.54B
毛利润:	CNY1.07B (69.58 %)
EPS:	CNY0.330

FY	2020
营收:	CNY1.32B
毛利润:	CNY877.41M (66.53 %)
EPS:	CNY-0.270

Financial Reports:

No articles found.

Vcanbio Cell & Gene

Vcanbio Cell & Gene Engineering Corp., Ltd, together with its subsidiaries, primarily engages in the preparation and storage of cell tests in the People's Republic of China. The company provides cell test preparation and storage services for umbilical cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental sub totipotent stem cells, immune cells, adipose stem cells, and dental stem cells. It also provides genetic testing services related to non-invasive prenatal genetic testing during pregnancy, safe medication guide gene testing for children and adults, disease genetic testing, disease susceptibility gene testing, etc.; and in vitro diagnostic raw materials, such as monoclonal antibodies and polyclonal antibody products. In addition, the company is involved in the research, development, production, and sales of biological genes, proteins, antibodies, pharmaceutical intermediates, and experimental synthetic agents; and in vitro diagnostic reagents and medical devices. Vcanbio Cell & Gene Engineering Corp., Ltd was founded in 1992 and is based in Tianjin, the People's Republic of China.